CY1106187T1 - REPRESSION GENE - Google Patents
REPRESSION GENEInfo
- Publication number
- CY1106187T1 CY1106187T1 CY20061101430T CY061101430T CY1106187T1 CY 1106187 T1 CY1106187 T1 CY 1106187T1 CY 20061101430 T CY20061101430 T CY 20061101430T CY 061101430 T CY061101430 T CY 061101430T CY 1106187 T1 CY1106187 T1 CY 1106187T1
- Authority
- CY
- Cyprus
- Prior art keywords
- gene
- modulating
- tumor suppressor
- encode polypeptides
- polypeptides capable
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 108700025716 Tumor Suppressor Genes Proteins 0.000 abstract 1
- 102000044209 Tumor Suppressor Genes Human genes 0.000 abstract 1
- 108010040002 Tumor Suppressor Proteins Proteins 0.000 abstract 1
- 102000001742 Tumor Suppressor Proteins Human genes 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 108700025694 p53 Genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Audible-Bandwidth Dynamoelectric Transducers Other Than Pickups (AREA)
- Bipolar Transistors (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Η εφεύρεση σχετίζεται με την ταυτοποίηση ενός νέου μέλους της οικογένειας των γονιδίων καταστολής νεοπλασίας (πρωτεϊνών διέγερσης της απόπτωσης ASP's) που κωδικοποιούν πολυπεπτίδια ικανά να διαμορφώνουν τη δράση του γονιδίου p53 και κωδικοποιούν επίσης και πολυπεπτίδια ικανά να διαμορφώνουν τη δράση του εν λόγω πολυπεπτιδίου καταστολής νεοπλασίας.The invention relates to the identification of a new member of the family of tumor suppressor genes (apoptosis stimulating proteins ASP's) that encode polypeptides capable of modulating the activity of the p53 gene and also encode polypeptides capable of modulating the action of said tumor suppressor polypeptide.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0019018A GB0019018D0 (en) | 2000-08-04 | 2000-08-04 | Suppressor gene |
GB0029996A GB0029996D0 (en) | 2000-12-08 | 2000-12-08 | Suppressor gene |
GB0112890A GB0112890D0 (en) | 2001-05-26 | 2001-05-26 | Suppressor Gene |
PCT/GB2001/003524 WO2002012325A2 (en) | 2000-08-04 | 2001-08-06 | Suppressor gene |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106187T1 true CY1106187T1 (en) | 2011-06-08 |
Family
ID=27255828
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20061101430T CY1106187T1 (en) | 2000-08-04 | 2006-10-04 | REPRESSION GENE |
Country Status (14)
Country | Link |
---|---|
US (1) | US20040053262A1 (en) |
EP (2) | EP1313762B1 (en) |
JP (1) | JP2004525605A (en) |
CN (1) | CN1310942C (en) |
AT (1) | ATE332309T1 (en) |
AU (2) | AU7651501A (en) |
CA (1) | CA2417368A1 (en) |
CY (1) | CY1106187T1 (en) |
DE (1) | DE60121346T8 (en) |
DK (1) | DK1313762T3 (en) |
ES (1) | ES2269430T3 (en) |
HK (1) | HK1057377A1 (en) |
PT (1) | PT1313762E (en) |
WO (1) | WO2002012325A2 (en) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6852108B2 (en) | 2002-05-14 | 2005-02-08 | Spiration, Inc. | Apparatus and method for resecting and removing selected body tissue from a site inside a patient |
ATE425183T1 (en) | 2002-10-07 | 2009-03-15 | Ludwig Inst For Cancer Res Ltd | P53 BINDING POLYPEPTIDE |
GB0223187D0 (en) * | 2002-10-07 | 2002-11-13 | Ludwig Inst Cancer Res | Screen |
EP1690094A1 (en) * | 2003-12-04 | 2006-08-16 | Ludwig Institute For Cancer Research | Screening assay and treatment |
WO2005054509A2 (en) * | 2003-12-04 | 2005-06-16 | Ludwig Institute For Cancer Research | Assay and treatment |
GB0328690D0 (en) | 2003-12-10 | 2004-01-14 | Ludwig Inst Cancer Res | Tumour suppressor protein |
WO2005093098A1 (en) * | 2004-03-12 | 2005-10-06 | Ludwig Institute For Cancer Research | Differential drug sensitivity |
EP1819827B1 (en) * | 2004-12-08 | 2010-08-11 | Cedars-Sinai Medical Center | Methods for diagnosis of crohn's disease |
US9051572B2 (en) | 2005-01-20 | 2015-06-09 | Ryboquin Company Limited | Modulators of Itch ubiquitinase activity |
US20100035257A1 (en) * | 2006-10-06 | 2010-02-11 | The General Hospital Corporation | Methods to determine the responsiveness to cisplatin treatment |
US20100021917A1 (en) * | 2007-02-14 | 2010-01-28 | Cedars-Sinai Medical Center | Methods of using genes and genetic variants to predict or diagnose inflammatory bowel disease |
US20100190162A1 (en) * | 2007-02-26 | 2010-07-29 | Cedars-Sinai Medical Center | Methods of using single nucleotide polymorphisms in the tl1a gene to predict or diagnose inflammatory bowel disease |
US20100015156A1 (en) * | 2007-03-06 | 2010-01-21 | Cedars-Sinai Medical Center | Diagnosis of inflammatory bowel disease in children |
WO2008116150A2 (en) | 2007-03-21 | 2008-09-25 | Cedars-Sinai Medical Center | Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease |
WO2008134569A2 (en) * | 2007-04-26 | 2008-11-06 | Cedars-Sinai Medical Center | Diagnosis and treatment of inflammatory bowel disease in the puerto rican population |
US20100144903A1 (en) * | 2007-05-04 | 2010-06-10 | Cedars-Sinai Medical Center | Methods of diagnosis and treatment of crohn's disease |
US20110177969A1 (en) * | 2008-10-01 | 2011-07-21 | Cedars-Sinai Medical Center | The role of il17rd and the il23-1l17 pathway in crohn's disease |
WO2010062960A2 (en) | 2008-11-26 | 2010-06-03 | Cedars-Sinai Medical Center | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE |
US9580752B2 (en) | 2008-12-24 | 2017-02-28 | Cedars-Sinai Medical Center | Methods of predicting medically refractive ulcerative colitis (MR-UC) requiring colectomy |
JP2013504586A (en) * | 2009-09-10 | 2013-02-07 | メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ | Methods and materials for modulating deubiquitinating enzymes and ubiquitinated polypeptides |
EP2820041B1 (en) | 2012-03-02 | 2017-06-14 | Ludwig Institute For Cancer Research Ltd. | Iaspp phosphorylation and metastatic potential |
BR112015024752A2 (en) | 2013-03-27 | 2017-07-18 | Cedars Sinai Medical Center | mitigation and reversal of fibrosis and inflammation through inhibition of tl1a function and related signaling pathways |
WO2015010108A1 (en) | 2013-07-19 | 2015-01-22 | Cedars-Sinai Medical Center | Signature of tl1a (tnfsf15) signaling pathway |
CN106874709B (en) * | 2015-12-12 | 2019-03-01 | 北京大学 | The detection and bearing calibration of sequence data mistake in sequencing result |
CA3005671A1 (en) | 2015-11-19 | 2017-05-26 | Peking University | Methods for obtaining and correcting biological sequence information |
US11186872B2 (en) | 2016-03-17 | 2021-11-30 | Cedars-Sinai Medical Center | Methods of diagnosing inflammatory bowel disease through RNASET2 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5876950A (en) * | 1995-01-26 | 1999-03-02 | Bristol-Myers Squibb Company | Monoclonal antibodies specific for different epitopes of human GP39 and methods for their use in diagnosis and therapy |
US5977311A (en) * | 1997-09-23 | 1999-11-02 | Curagen Corporation | 53BP2 complexes |
EP1117791A2 (en) * | 1998-10-05 | 2001-07-25 | Ludwig Institute For Cancer Research | Cancer associated antigens and uses therefor |
US7141384B1 (en) * | 1998-10-06 | 2006-11-28 | Georgetown University | Detection of pleiotrophin |
EP1146054A4 (en) * | 1998-12-03 | 2003-08-06 | Ono Pharmaceutical Co | ReL1A BINDING INHIBITOR, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF |
CA2402563A1 (en) * | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
WO2001057190A2 (en) * | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
-
2001
- 2001-08-06 WO PCT/GB2001/003524 patent/WO2002012325A2/en active IP Right Grant
- 2001-08-06 EP EP01954168A patent/EP1313762B1/en not_active Expired - Lifetime
- 2001-08-06 DE DE60121346T patent/DE60121346T8/en active Active
- 2001-08-06 PT PT01954168T patent/PT1313762E/en unknown
- 2001-08-06 CN CNB018138594A patent/CN1310942C/en not_active Expired - Fee Related
- 2001-08-06 DK DK01954168T patent/DK1313762T3/en active
- 2001-08-06 AU AU7651501A patent/AU7651501A/en active Pending
- 2001-08-06 CA CA002417368A patent/CA2417368A1/en not_active Abandoned
- 2001-08-06 AT AT01954168T patent/ATE332309T1/en not_active IP Right Cessation
- 2001-08-06 AU AU2001276515A patent/AU2001276515B2/en not_active Ceased
- 2001-08-06 JP JP2002518296A patent/JP2004525605A/en active Pending
- 2001-08-06 EP EP06076277A patent/EP1710582A3/en not_active Withdrawn
- 2001-08-06 ES ES01954168T patent/ES2269430T3/en not_active Expired - Lifetime
- 2001-08-06 US US10/343,649 patent/US20040053262A1/en not_active Abandoned
-
2003
- 2003-11-28 HK HK03108730A patent/HK1057377A1/en not_active IP Right Cessation
-
2006
- 2006-10-04 CY CY20061101430T patent/CY1106187T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2001276515B2 (en) | 2006-10-12 |
DE60121346T8 (en) | 2007-12-13 |
DE60121346D1 (en) | 2006-08-17 |
ES2269430T3 (en) | 2007-04-01 |
WO2002012325A2 (en) | 2002-02-14 |
EP1313762A2 (en) | 2003-05-28 |
EP1710582A2 (en) | 2006-10-11 |
AU7651501A (en) | 2002-02-18 |
ATE332309T1 (en) | 2006-07-15 |
WO2002012325A3 (en) | 2003-03-06 |
HK1057377A1 (en) | 2004-04-02 |
EP1313762B1 (en) | 2006-07-05 |
EP1710582A3 (en) | 2006-11-02 |
CA2417368A1 (en) | 2002-02-14 |
PT1313762E (en) | 2006-11-30 |
CN1310942C (en) | 2007-04-18 |
US20040053262A1 (en) | 2004-03-18 |
DE60121346T2 (en) | 2007-07-19 |
JP2004525605A (en) | 2004-08-26 |
DK1313762T3 (en) | 2006-10-30 |
CN1446228A (en) | 2003-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106187T1 (en) | REPRESSION GENE | |
CY1105895T1 (en) | SOLUBLE INTEPLEUKIN-6 RECEPTOR/BINDER CHIMERIC PROTEIN, THEREOF AND USES THEREOF | |
DK0670899T3 (en) | Heat shock proteins and treatment of tumors | |
ATE332368T1 (en) | SELECTION OF PROTEINS USING RNA-PROTEIN FUSIONS | |
BR0316435A (en) | Genetic products differentially expressed in and use of tumors | |
ATE371727T1 (en) | KDR, A HUMAN TYROSINE KINASE RECEPTOR | |
DE69900746D1 (en) | CONTROLLED ADMINISTRATION OF PEPTIDES OR PROTEINS | |
DE69421624D1 (en) | MEDICINE BINDING PROTEIN | |
DK1121382T3 (en) | Interferon-beta fusion proteins and their applications | |
CY1106323T1 (en) | TRANSGENIC INSECT-RESISTANT PLANTS AND METHODS OF IMPROVING DELTA-ENDOTOXIN ACTIVITY AGAINST INSECT TARGETS | |
EA200000311A1 (en) | NEW PROTEIN IMMUNE SYSTEM - KAU | |
DE60041505D1 (en) | INTEGRITY PROTEINS OF BACILLUS THURINGIENSIS | |
PT839194E (en) | VARIANT PROTEIN P53 AND THERAPEUTIC UTILIZATIONS. | |
CY1105380T1 (en) | PREFERRED NEURAL FILAMENT PROTEIN PORTIONS AND METHODS OF USING THEREOF | |
NO971059D0 (en) | Modified human C3 proteins | |
ATE439441T1 (en) | MODIFIED FLUORESCENT PROTEINS | |
DK1082423T3 (en) | Cyclin E2 genes and proteins | |
BR9710919A (en) | Purified protein sr-p70 | |
DK0804577T3 (en) | cDNA encoding a BMP type II receptor | |
DE69831231D1 (en) | MODULATORS OF INTRA-CELLULAR INFLAMMATORY, CELL-DATE, AND CELL-LIFE PATHS THAT CONTAIN CARD AND KINASE DOMAINS | |
YU21292A (en) | INSECTICIDALLY EFFECTIVE PEPTIDES | |
ATE389403T1 (en) | INHIBITORS OF PEPTIDE DEFORMYLASE | |
PT1140994E (en) | PROTEINS OF THE EXTERNAL SURFACE, THEIR GENES AND THEIR USE | |
PT870015E (en) | NEW XYLANESES THE GENES THAT ENCODE THEM AND THEIR USES | |
ATE300294T1 (en) | INHIBITORS OF PEPTIDE DEFORMYLASE |